Get the Stockscreener App
8.54
3.26%
0.27
Kamada Ltd stock is traded at $8.54, with a volume of 160.68K.
It is up +3.26% in the last 24 hours and up +16.35% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$8.27
Open:
$8.32
24h Volume:
160.68K
Relative Volume:
2.33
Market Cap:
$492.71M
Revenue:
$181.68M
Net Income/Loss:
$20.37M
P/E Ratio:
24.43
EPS:
0.3495
Net Cash Flow:
$17.31M
1W Performance:
+3.02%
1M Performance:
+16.35%
6M Performance:
-7.07%
1Y Performance:
+20.96%
1-Day Range:
$8.32
$8.60
1-Week Range:
$8.13
$8.60
52-Week Range:
$6.50
$9.35
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
8.54 | 462.71M | 181.68M | 20.37M | 17.31M | 0.3495 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Israeli fund’s Kamada (NASDAQ: KMDA) holding tops 2.6M shares - Stock Titan
Kamada (KMDA) EPS and Revenue: The Bottom-Line Figure Beats Its Comparison in the Latest Session; Trading Response: Shares Move 0.51% Up for the Current SessionTrough Earnings Signal - vinanet.vn
Sidoti Comments on Kamada's FY2028 Earnings (NASDAQ:KMDA) - MarketBeat
Sidoti Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat
HC Wainwright Analysts Boost Earnings Estimates for Kamada - MarketBeat
Kamada Declares Cash Dividend of $0.17 per Share, the Company Reported Record-High Revenue and Profitability for First Six Months of 2026 - marketscreener.com
Kamada Ltd. (NASDAQ:KMDA) Declares $0.17 Annual Dividend - MarketBeat
Kamada Declares $0.17 Dividend After Record-High First-Half 2026 Results - TipRanks
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026 - marketscreener.com
Record H1 2026 lifts Kamada (KMDA) to cash dividend - Stock Titan
HC Wainwright Has Negative Outlook of Kamada FY2027 Earnings - MarketBeat
KMDA|Kamada Ltd|Price:7.565|Chg%:+0.305 - TradingKey
Wall Street Analysts Think Kamada (KMDA) Could Surge 79.06%: Read This Before Placing a Bet - Yahoo Finance
Sidoti Equities Analysts Raise Earnings Estimates for Kamada - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Kamada (KMDA) Surges 5.4% Toward Resistance After Bouncing Off $6.89 SupportThematic ETF Flow - vinanet.vn
Should Value Investors Buy Kamada (KMDA) Stock? - Yahoo Finance
Kamada Delivers Record First-Half 2026 Results and Secures $50 Million Plasma Supply Deal - The Globe and Mail
Kamada CFO Chaime Orlev to step down after nine years By Investing.com - Investing.com Australia
Kamada Ltd (KMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Expansion ... - Yahoo Finance
Kamada Ltd (KMDA) (Q2 2026) Earnings Call Highlights: Record Rev - GuruFocus
Kamada Q2 2026 EPS Tops Expectations, Revenue Up 23% - AlphaStreet
Kamada Ltd. Q2 2026 Earnings Call: Plasma-Derived Portfolio and Commercial Execution in Focus - vinanet.vn
Kamada Releases Q2 2026 Financial Results - AlphaStreet
Kamada Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
Kamada Q2 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Kamada tops Q2 2026 estimates as growth stays steady - Investing.com
Kamada Ltd. reports results for the quarter ended June 30Earnings Summary - TradingView
Kamada (KMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - ca.finance.yahoo.com
Kamada reports record H1 revenues of $100.2M, up 13% YoY By Investing.com - Investing.com Australia
Kamada CFO Chaime Orlev to step down after nine years - Investing.com India
Kamada Announces Planned Transition of Chief Financial Officer - The Manila Times
Kamada: Q2 Earnings Snapshot - 10TV
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance - marketscreener.com
Kamada (KMDA) delivers record H1 2026 growth and reaffirms double-digit 2026 guidance - Stock Titan
Kamada Secures 3-Year, ~$50M Plasma Deal; Sales Expected Q4 - Stock Titan
Kamada CFO Chaime Orlev to Exit Role After Nine Years - Stock Titan
Earnings To Watch: Kamada Ltd (KMDA) Q2 2026 -- GF Value Sees 32% Upside - GuruFocus
Kamada Ltd. expected to post earnings of 11 cents a shareEarnings Preview - TradingView
Curious about Kamada (KMDA) Q2 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance Singapore
Kamada Ltd Director Uri Botzer Granted 30,000 Stock Options Under 2011 Plan - Kalkine Media
Form 4 KAMADA LTD For: 6 August By Investing.com - Investing.com South Africa
Options Exercise Activity Initiated By Leon Recanati At Kamada Worth $0 - Benzinga
Breaking Update: Assaf Itshayek Engages In Options Exercise At Kamada Realizing $0 - Benzinga
Uri Botzer At Kamada Exercises Options Worth $0 - benzinga.com
Kamada (KMDA) awards director 30,000 stock options at $7.52 - Stock Titan
Kamada Ltd (KMDA) director receives 30,000 stock option grant - stocktitan.net
Kamada (KMDA) awards 30,000 stock options to director Karnit Goldwasser - stocktitan.net
Kamada (KMDA) director receives 30,000 options at $7.5200 strike price - Stock Titan
Kamada (KMDA) director receives grant of 30,000 stock options - Stock Titan
Kamada Shareholders Approve Director Slate, Equity Plan Changes and Auditor for 2026 - TipRanks
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):